Benztropine
Benztropine is a prescription medication used to help manage parkinsonism and to control drug-induced movement side effects (extrapyramidal disorders) caused by certain antipsychotic medications.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 31 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Benztropine: Patient Information Guide
A plain-language walkthrough of Benztropine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Benztropine mesylate is used to help manage movement problems in two main situations:
- Parkinsonism: Benztropine Mesylate tablets and Benztropine Mesylate injection are both approved as part of the treatment for all forms of parkinsonism — including idiopathic (the most common type), postencephalitic (following a brain infection), and drug-induced parkinsonism.
- Drug-induced extrapyramidal disorders: Both the tablet and injection forms are used to control abnormal involuntary muscle movements and stiffness triggered by antipsychotic drugs such as phenothiazines. This includes acute reactions that may require rapid treatment.
- Not for tardive dyskinesia: Benztropine is specifically not approved to treat tardive dyskinesia (the uncontrolled repetitive movements that can develop after long-term antipsychotic use).
⚙️How it works▾
Benztropine works mainly by blocking acetylcholine — a chemical messenger in the brain and nervous system. In parkinsonism, there is an imbalance between acetylcholine and dopamine in the parts of the brain that control movement. By blocking acetylcholine's effects (anticholinergic action), benztropine helps restore that balance and ease symptoms like stiffness and tremor. It also has antihistamine properties similar to older antihistamines, but this effect is not what makes it helpful for parkinsonism.
💊How it's taken▾
Benztropine mesylate is available as an oral tablet and as an injection. The tablet is taken by mouth — once daily (often at bedtime, since its effects last through the night) or in divided doses, depending on what works best for you. The injection is given by a healthcare provider into a muscle or vein and is reserved for situations where oral medication isn't possible or when fast relief is needed.
- Dosing always starts low and is increased gradually over several days — never jump to a higher dose quickly.
- Do not stop other Parkinson's medications suddenly when starting benztropine; your doctor will reduce them slowly.
- Benztropine can be taken with other Parkinson's drugs like levodopa or carbidopa-levodopa — your prescriber will adjust doses as needed.
🤒Side effects — in detail▾
The most common side effects of benztropine are related to its anticholinergic (acetylcholine-blocking) action:
- Dry mouth — if severe enough to make swallowing or speaking difficult, contact your doctor
- Constipation
- Nausea or vomiting
- Blurred vision and dilated pupils
- Difficulty urinating
- Rapid heartbeat (tachycardia)
- Numbness of fingers
- Confusion, memory problems, or hallucinations — especially at higher doses
Serious reactions that need prompt medical attention include signs of overheating (hot, dry skin; no sweating; high body temperature), paralytic ileus (gut stops moving), heat stroke, and toxic psychosis (severe confusion or hallucinations).
⚠️Warnings & precautions▾
- Reduced sweating and overheating: Benztropine can stop you from sweating normally (anhidrosis), which makes it impossible for your body to cool down. This can lead to dangerous overheating (hyperthermia) or fatal heat stroke — especially in hot weather, during physical activity, or if you take other anticholinergic drugs. If you notice you've stopped sweating, seek medical help right away.
- Serious drug combinations: Taking benztropine with antipsychotics (phenothiazines, haloperidol) or tricyclic antidepressants greatly increases the risk of heat stroke, paralytic ileus, and other life-threatening anticholinergic effects. Report any stomach pain, fever, or heat intolerance to your doctor immediately.
- Driving and machinery: Benztropine can impair your thinking and physical reactions. Avoid driving or operating dangerous equipment until you know how it affects you.
- Pregnancy: The safety of benztropine during pregnancy has not been established. Talk to your doctor if you are pregnant or planning to become pregnant.
🔀What it interacts with▾
Benztropine can interact with other medications in ways that increase the risk of serious side effects:
- Phenothiazines and haloperidol (antipsychotics): Combining these with benztropine raises the risk of heat stroke, paralytic ileus (gut stoppage), and severe anticholinergic toxicity — some cases have been fatal.
- Tricyclic antidepressants: These also have anticholinergic properties; using them with benztropine amplifies the risk of dangerous overheating, gut problems, and other serious effects.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Children under 3: Benztropine is contraindicated (must not be used) in children younger than 3 years old. It should be used cautiously in older children.
- Older adults and people with low body weight: These patients tend to be more sensitive and generally cannot tolerate higher doses safely.
- Hot environments and physical labor: If you work outdoors in heat or do heavy physical work, you face a higher risk of dangerous overheating because benztropine reduces sweating.
- Chronic illness, alcohol use, or CNS disease: These conditions increase sensitivity to the drug's anticholinergic effects and the risk of overheating.
- Pregnancy: Safe use during pregnancy has not been established — discuss the risks and benefits with your prescriber.
- Poor mental outlook or significant psychiatric illness: Patients with these conditions may be poor candidates for benztropine therapy; the drug can worsen confusion and psychotic symptoms.
🚑If you take too much▾
Taking too much benztropine can cause a wide range of serious symptoms, including confusion, hallucinations, agitation, dizziness, muscle weakness, rapid heartbeat, high blood pressure, severe dry mouth, difficulty swallowing, inability to urinate, hot and flushed skin, and in severe cases, seizures, coma, or respiratory arrest. If you suspect an overdose, call emergency services or Poison Control immediately. Medical treatment may include a medication called physostigmine salicylate to reverse anticholinergic effects, along with supportive care tailored to the specific symptoms.
📡Pharmacodynamics — effects in the body▾
Benztropine blocks the action of acetylcholine (an anticholinergic effect), which helps rebalance the brain chemistry disrupted in parkinsonism. This leads to reduced muscle stiffness, tremors, and involuntary movements. It also has antihistamine effects similar to older antihistamine drugs, though this property is not considered clinically meaningful for treating parkinsonism.
📦How to store it▾
Dispense in a well-closed container as defined in the USP. Store at 20° to 25°C (68° to 77°F) .
📄 Written from Benztropine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Benztropine
46 supplements and herbal products have documented interactions with Benztropine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 3
- Moderate · 32
- Minor · 11
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Benztropine — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is benztropine supposed to do for me? ▾
Should I take my tablet in the morning or at night? ▾
What side effects should I actually expect — and which ones should make me call my doctor? ▾
Can I stop taking my other Parkinson's medications now that I'm starting benztropine? ▾
Is it safe to be outside in the heat while taking this medication? ▾
Is this medication safe to take during pregnancy? ▾
Is Benztropine available over the counter? ▾
When was Benztropine first available? ▾
Who makes Benztropine? ▾
💬 Answers drafted from Benztropine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Benztropine comes
Benztropine is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Benztropine Mesylate tablets are used as part of the treatment for all forms of parkinsonism
- Benztropine Mesylate tablets are used to control drug-induced extrapyramidal disorders (abnormal muscle movements) caused by antipsychotics such as phenothiazines — but not tardive dyskinesia
- Benztropine Mesylate tablets should be used when a patient is able to swallow oral medication
- The dose is started low and increased slowly every five to six days until the best response is reached — follow your prescriber's schedule exactly
- Some patients do best taking the full daily dose at bedtime; others do better with doses split two to four times a day — your prescriber will advise which works for you
- Do not stop other Parkinson's medications abruptly when starting Benztropine Mesylate tablets — any changes must be made gradually under your doctor's guidance
Injection
How this form is used
- Benztropine Mesylate injection is used as part of the treatment for all forms of parkinsonism
- Benztropine Mesylate injection is used to control drug-induced extrapyramidal disorders caused by antipsychotics — but not tardive dyskinesia
- Benztropine Mesylate injection is used in emergency situations when rapid relief of severe parkinsonian symptoms is needed
- Benztropine Mesylate injection is given by a healthcare provider into a muscle (intramuscular) or into a vein (intravenous); improvement can be noticeable within a few minutes
- There is no meaningful difference in how fast the intramuscular and intravenous routes work, so the intravenous route is not usually necessary
- Benztropine Mesylate tablets should be used in place of the injection as soon as the patient is able to take oral medication
- Dosing is started low and increased gradually every five to six days — the prescriber determines the right amount based on the patient's age, weight, and type of parkinsonism
📊 Benztropine across the U.S. market
How Benztropine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (7) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Benztropine is used
A general measure of how commonly Benztropine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Benztropine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Benztropine prescribed? Of the 1,596 medications we measure, Benztropine ranks #141 by Medicaid prescriptions — more than 91% of them.
Utilization by Benztropine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
benztropine mesylate 1 MG Oral Tablet Most dispensed
Summed across the 14 of 74 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 885213
benztropine mesylate 0.5 MG Oral Tablet
Summed across the 11 of 53 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 885219
benztropine mesylate 2 MG Oral Tablet
Summed across the 13 of 58 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 885209
2 ML benztropine mesylate 1 MG/ML Injection
Summed across the 2 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 885205
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Benztropine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 40 of 195 listed Benztropine NDCs with Medicaid activity.
🔍 Compare Benztropine products
A representative set of FDA-listed product records for Benztropine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 1 mg/mL | Intramuscular, Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 1 mg/mL | Intramuscular; Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 1 mg/mL | Intramuscular; Intravenous | Hikma Pharmaceuticals USA Inc. × 3 listings | ANDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous | Navinta LLC | ANDA | View NDC → |
| 1 mg/mL | Intramuscular; Intravenous | Navinta LLC × 2 listings | ANDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 1 mg/mL | Intramuscular; Intravenous | Zydus Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 💊Tablet | ||||
| 1 mg | Oral | A-S Medication Solutions × 4 listings | ANDA | View NDC → |
| 2 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | Find on DailyMed ↗ |
| 0.5 mg | Oral | American Health Packaging × 4 listings | ANDA | View NDC → |
| 1 mg | Oral | American Health Packaging × 4 listings | ANDA | View NDC → |
| 2 mg | Oral | American Health Packaging × 5 listings | ANDA | View NDC → |
| 1 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC | ANDA | View NDC → |
| 0.5 mg | Oral | Aphena Pharma Solutions - Tennnessee, LLC | ANDA | Find on DailyMed ↗ |
| 1 mg | Oral | Aphena Pharma Solutions - Tennnessee, LLC × 2 listings | ANDA | View NDC → |
| 0.5 mg | Oral | Bayshore Pharmaceuticals LLC (NJ) | ANDA | View NDC → |
| 1 mg | Oral | Bayshore Pharmaceuticals LLC (NJ) | ANDA | View NDC → |
| 2 mg | Oral | Bayshore Pharmaceuticals LLC (NJ) | ANDA | View NDC → |
| 0.5 mg | Oral | Bryant Ranch Prepack × 6 listings | ANDA | View NDC → |
| 1 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | Bryant Ranch Prepack × 7 listings | ANDA | View NDC → |
| 1 mg | Oral | Cardinal Health 107, LLC | ANDA | View NDC → |
| 0.5 mg | Oral | Chartwell RX, LLC. × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Chartwell RX, LLC. × 3 listings | ANDA | View NDC → |
| 2 mg | Oral | Chartwell RX, LLC. × 3 listings | ANDA | View NDC → |
| 0.5 mg | Oral | Cipla USA Inc. | ANDA | View NDC → |
| 1 mg | Oral | Cipla USA Inc. | ANDA | View NDC → |
| 2 mg | Oral | Cipla USA Inc. | ANDA | View NDC → |
| 1 mg | Oral | Clinical Solutions Wholesale, LLC | ANDA | View NDC → |
| 0.5 mg | Oral | Coupler LLC × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 2 mg | Oral | Coupler LLC × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | Direct Rx × 2 listings | ANDA | View NDC → |
| 0.5 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 1 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 0.5 mg | Oral | Leading Pharma, LLC | ANDA | View NDC → |
| 1 mg | Oral | Leading Pharma, LLC | ANDA | View NDC → |
| 2 mg | Oral | Leading Pharma, LLC | ANDA | View NDC → |
| 0.5 mg | Oral | Major Pharmaceuticals × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | Major Pharmaceuticals × 3 listings | ANDA | View NDC → |
| 2 mg | Oral | Major Pharmaceuticals × 3 listings | ANDA | View NDC → |
| 0.5 mg | Oral | Marlex PHARMACEUTICAL, INC | ANDA | View NDC → |
| 1 mg | Oral | Marlex PHARMACEUTICAL, INC | ANDA | View NDC → |
| 2 mg | Oral | Marlex PHARMACEUTICAL, INC | ANDA | View NDC → |
| 0.5 mg | Oral | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | View NDC → |
| 1 mg | Oral | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | View NDC → |
| 2 mg | Oral | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | View NDC → |
| 0.5 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs × 2 listings | ANDA | View NDC → |
| 0.5 mg | Oral | Par Pharmaceutical, Inc. × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | Par Pharmaceutical, Inc. × 3 listings | ANDA | View NDC → |
| 2 mg | Oral | Par Pharmaceutical, Inc. × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 0.5 mg | Oral | Quagen Pharmaceuticals Llc | ANDA | View NDC → |
| 1 mg | Oral | Quagen Pharmaceuticals Llc | ANDA | View NDC → |
| 2 mg | Oral | Quagen Pharmaceuticals Llc | ANDA | View NDC → |
| 0.5 mg | Oral | Remedyrepack Inc. × 6 listings | ANDA | View NDC → |
| 1 mg | Oral | Remedyrepack Inc. × 11 listings | ANDA | View NDC → |
| 2 mg | Oral | Remedyrepack Inc. × 5 listings | ANDA | View NDC → |
| 0.5 mg | Oral | ScieGen Pharmaceuticals Inc | ANDA | View NDC → |
| 1 mg | Oral | ScieGen Pharmaceuticals Inc | ANDA | View NDC → |
| 2 mg | Oral | ScieGen Pharmaceuticals Inc | ANDA | View NDC → |
| 0.5 mg | Oral | Sunrise Pharmaceutical, Inc | ANDA | View NDC → |
| 1 mg | Oral | Sunrise Pharmaceutical, Inc | ANDA | View NDC → |
| 2 mg | Oral | Sunrise Pharmaceutical, Inc | ANDA | View NDC → |
| 1 mg | Oral | Unit Dose Solutions, Inc. × 2 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 4.999 kg/4.999 kg | — | Apothecon Pharmaceuticals Pvt Ltd | BULK INGREDIENT | View NDC → |
| 50 kg/50 kg | — | Escientia Advanced Sciences Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Fine Chemicals Corporation (PTY) Ltd. | BULK INGREDIENT | View NDC → |
| 25 kg/25 kg | — | Harman Finochem Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Kalintis Healthcare Private Limited | BULK INGREDIENT | View NDC → |
| 5 kg/5 kg | — | Par Active Technologies Private Limited | BULK INGREDIENT | View NDC → |
| 100 g/100 g | — | Siegfried Grafton, Inc. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
Showing 151 of 151 products — FDA National Drug Code Directory. See every product, package size and price: browse all 151 Benztropine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Benztropine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Benztropine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Benztropine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 1424 2 dose forms · 4 strengths
-
Dose form (SCDF) Injection RxCUI 1726504In current FDA listingsClinical drug / strength (SCD) 2 ML benztropine mesylate 1 MG/MLRxCUI 885205 -
Dose form (SCDF) Oral Tablet RxCUI 371038In current FDA listingsClinical drug / strength (SCD) mesylate 0.5 MGRxCUI 885219mesylate 1 MGRxCUI 885213mesylate 2 MGRxCUI 885209
Look up RxCUI 1424 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Benztropine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 12 more on the FDA NDC directory.
RxNorm drug class
Benztropine belongs to the Anticholinergic class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 31 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Cipla USA Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.